| Product Code: ETC10185486 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India primary immune deficiency market import shipment demonstrated remarkable growth with a high CAGR from 2020 to 2024. The growth rate further accelerated between 2023 and 2024, indicating a significant expansion trend in the market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Primary Immune Deficiency Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Primary Immune Deficiency Market Revenues & Volume, 2021 & 2031F |
3.3 India Primary Immune Deficiency Market - Industry Life Cycle |
3.4 India Primary Immune Deficiency Market - Porter's Five Forces |
3.5 India Primary Immune Deficiency Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 India Primary Immune Deficiency Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 India Primary Immune Deficiency Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.8 India Primary Immune Deficiency Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Primary Immune Deficiency Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about primary immune deficiency disorders in India |
4.2.2 Growing healthcare infrastructure and access to specialized treatments |
4.2.3 Rising prevalence of autoimmune diseases and genetic disorders in the country |
4.3 Market Restraints |
4.3.1 Limited diagnostic facilities and testing services for primary immune deficiency disorders |
4.3.2 High cost of treatment and therapies for patients |
4.3.3 Lack of skilled healthcare professionals specialized in managing primary immune deficiency disorders |
5 India Primary Immune Deficiency Market Trends |
6 India Primary Immune Deficiency Market, By Types |
6.1 India Primary Immune Deficiency Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 India Primary Immune Deficiency Market Revenues & Volume, By Disease Type, 2021 - 2031F |
6.1.3 India Primary Immune Deficiency Market Revenues & Volume, By Common Variable Immunodeficiency, 2021 - 2031F |
6.1.4 India Primary Immune Deficiency Market Revenues & Volume, By Severe Combined Immunodeficiency, 2021 - 2031F |
6.1.5 India Primary Immune Deficiency Market Revenues & Volume, By X-Linked Agammaglobulinemia, 2021 - 2031F |
6.1.6 India Primary Immune Deficiency Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 India Primary Immune Deficiency Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 India Primary Immune Deficiency Market Revenues & Volume, By Immunoglobulin Therapy, 2021 - 2031F |
6.2.3 India Primary Immune Deficiency Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.2.4 India Primary Immune Deficiency Market Revenues & Volume, By Stem Cell Transplant, 2021 - 2031F |
6.2.5 India Primary Immune Deficiency Market Revenues & Volume, By Antibiotic Therapy, 2021 - 2031F |
6.3 India Primary Immune Deficiency Market, By Drug Class |
6.3.1 Overview and Analysis |
6.3.2 India Primary Immune Deficiency Market Revenues & Volume, By IVIG, 2021 - 2031F |
6.3.3 India Primary Immune Deficiency Market Revenues & Volume, By SCIG, 2021 - 2031F |
6.3.4 India Primary Immune Deficiency Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.3.5 India Primary Immune Deficiency Market Revenues & Volume, By Immunosuppressants, 2021 - 2031F |
6.4 India Primary Immune Deficiency Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India Primary Immune Deficiency Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 India Primary Immune Deficiency Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 India Primary Immune Deficiency Market Revenues & Volume, By Specialty Centers, 2021 - 2031F |
6.4.5 India Primary Immune Deficiency Market Revenues & Volume, By Homecare, 2021 - 2031F |
7 India Primary Immune Deficiency Market Import-Export Trade Statistics |
7.1 India Primary Immune Deficiency Market Export to Major Countries |
7.2 India Primary Immune Deficiency Market Imports from Major Countries |
8 India Primary Immune Deficiency Market Key Performance Indicators |
8.1 Number of patients diagnosed with primary immune deficiency disorders annually |
8.2 Rate of adoption of advanced treatment options for primary immune deficiency disorders |
8.3 Percentage of healthcare facilities offering specialized care for primary immune deficiency disorders |
8.4 Average time taken for diagnosis and initiation of treatment for primary immune deficiency disorders |
9 India Primary Immune Deficiency Market - Opportunity Assessment |
9.1 India Primary Immune Deficiency Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 India Primary Immune Deficiency Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 India Primary Immune Deficiency Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.4 India Primary Immune Deficiency Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Primary Immune Deficiency Market - Competitive Landscape |
10.1 India Primary Immune Deficiency Market Revenue Share, By Companies, 2024 |
10.2 India Primary Immune Deficiency Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here